522 related articles for article (PubMed ID: 37833700)
21. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
[TBL] [Abstract][Full Text] [Related]
22. A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease.
El-Sappagh S; Alonso JM; Islam SMR; Sultan AM; Kwak KS
Sci Rep; 2021 Jan; 11(1):2660. PubMed ID: 33514817
[TBL] [Abstract][Full Text] [Related]
23. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
[TBL] [Abstract][Full Text] [Related]
24. Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
Li H; Liu H; Lutz MW; Luo S;
J Alzheimers Dis; 2023; 91(3):977-987. PubMed ID: 36530083
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
26. Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment.
Li L; Yang Y; Zhang Q; Wang J; Jiang J; Neuroimaging Initiative AD
Behav Neurol; 2021; 2021():3359103. PubMed ID: 34336000
[TBL] [Abstract][Full Text] [Related]
27. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
28. Data-Limited Deep Learning Methods for Mild Cognitive Impairment Classification in Alzheimer's Disease Patients.
De Luna A; Marcia RF
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2641-2646. PubMed ID: 34891795
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis.
Shigemizu D; Mori T; Akiyama S; Higaki S; Watanabe H; Sakurai T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Jul; 12(1):87. PubMed ID: 32677993
[TBL] [Abstract][Full Text] [Related]
30. Deep Learning for Alzheimer's Disease Classification using Texture Features.
So JH; Madusanka N; Choi HK; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):689-698. PubMed ID: 32008517
[TBL] [Abstract][Full Text] [Related]
31. A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer's disease.
Zhang Y; Xue L; Zhang S; Yang J; Zhang Q; Wang M; Wang L; Zhang M; Jiang J; Li Y;
Alzheimers Res Ther; 2024 Mar; 16(1):60. PubMed ID: 38481280
[TBL] [Abstract][Full Text] [Related]
32. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
[TBL] [Abstract][Full Text] [Related]
33. VGG-TSwinformer: Transformer-based deep learning model for early Alzheimer's disease prediction.
Hu Z; Wang Z; Jin Y; Hou W
Comput Methods Programs Biomed; 2023 Feb; 229():107291. PubMed ID: 36516516
[TBL] [Abstract][Full Text] [Related]
34. Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease.
Popescu SG; Whittington A; Gunn RN; Matthews PM; Glocker B; Sharp DJ; Cole JH;
Hum Brain Mapp; 2020 Oct; 41(15):4406-4418. PubMed ID: 32643852
[TBL] [Abstract][Full Text] [Related]
35. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.
Toledo JB; Weiner MW; Wolk DA; Da X; Chen K; Arnold SE; Jagust W; Jack C; Reiman EM; Davatzikos C; Shaw LM; Trojanowski JQ;
Acta Neuropathol Commun; 2014 Mar; 2():26. PubMed ID: 24602322
[TBL] [Abstract][Full Text] [Related]
36. Multipredictor risk models for predicting individual risk of Alzheimer's disease.
Hou XH; Suckling J; Shen XN; Liu Y; Zuo CT; Huang YY; Li HQ; Wang HF; Tan CC; Cui M; Dong Q; Tan L; Yu JT;
J Transl Med; 2023 Oct; 21(1):768. PubMed ID: 37904154
[TBL] [Abstract][Full Text] [Related]
37. Deep learning-based identification of genetic variants: application to Alzheimer's disease classification.
Jo T; Nho K; Bice P; Saykin AJ;
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35183061
[TBL] [Abstract][Full Text] [Related]
38. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
Elife; 2023 Jan; 12():. PubMed ID: 36607335
[TBL] [Abstract][Full Text] [Related]
39. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
40. Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.
Ezzati A; Zammit AR; Harvey DJ; Habeck C; Hall CB; Lipton RB;
J Alzheimers Dis; 2019; 71(3):1027-1036. PubMed ID: 31476152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
